Andrew Wooten appointed vice president of commercialization
Andrew Wooten assumed the role of vice president of the Center for Technology Commercialization (CTC) on January 3. In that capacity, he leads the development and commercialization of all Cincinnati Children’s intellectual property—including research partnerships, licensing and new ventures.
“One of our top priorities at Cincinnati Children’s is sharing our ideas, our discoveries and our advancements so that children in Cincinnati and around the world can thrive,” said Peggy Hostetter, MD, director, Research Foundation. “The interaction of our innovative faculty with the CTC is critical to our success in this arena, and I’m excited for what the CTC will accomplish under Andrew’s leadership.”
Wooten comes to Cincinnati Children’s from Baylor College of Medicine, where he was the founding executive director of the Innovation Development Center. Prior to that, he held positions in industry, academia, and as a biotechnology entrepreneur.
“My hope is to build on a great foundation with the CTC and elevate Cincinnati Children’s pediatric innovation programs to even greater levels of success. I look forward to working with our innovators, the regional ecosystem, and our partners in industry and venture to continue to do everything we can to be the leader in improving child health.”
Wooten received a bachelor’s degree in chemistry from Berea College, a master’s in biotechnology from University of Georgia, and his MBA from Mercer University.
